Oxaliplatin, 5-fluorouracil, and leuvocorin and (FOLFOX-4) combination chemotherapy as salvage treatment in pretreated patients with advanced gastric cancer (AGC)

被引：1
|
作者：
Kim, Y. [1 ]
Park, S. [1 ]
Park, J. [1 ]
Cho, E. [1 ]
Shin, D. [1 ]
Lee, J. [1 ]
机构：
[1] Gachon Univ, Gil Med Ctr, Inchon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4577
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Phase I/II docetaxel, oxaliplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Kim, Sung Rok
    Park, Sung-En
    Yuh, Young Jin
    Sohn, Byeong Seok
    Lee, Hye Ran
    Song, Hong-Suk
    Lee, Kyung-Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [12] A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
    F De Vita
    M Orditura
    E Matano
    R Bianco
    C Carlomagno
    S Infusino
    V Damiano
    E Simeone
    M R Diadema
    E Lieto
    P Castellano
    S Pepe
    S De Placido
    G Galizia
    N Di Martino
    F Ciardiello
    G Catalano
    A R Bianco
    British Journal of Cancer, 2005, 92 : 1644 - 1649
  • [13] Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: A Korean single-center experience
    Park, SH
    Sung, JY
    Han, SH
    Baek, JH
    Oh, JH
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (09) : 531 - 535
  • [14] A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
    De Vita, F
    Orditura, M
    Matano, E
    Bianco, R
    Carlomagno, C
    Infusino, S
    Damiano, V
    Simeone, E
    Diadema, MR
    Lieto, E
    Castellano, P
    Pepe, S
    De Placido, S
    Galizia, G
    Di Martino, N
    Ciardiello, F
    Catalano, G
    Bianco, AR
    BRITISH JOURNAL OF CANCER, 2005, 92 (09) : 1644 - 1649
  • [15] Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin in patients with advanced gastric cancer
    Sym, Sun Jin
    ANNALS OF ONCOLOGY, 2006, 17 : 315 - 315
  • [16] Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan
    Chihiro Kondoh
    Shigenori Kadowaki
    Azusa Komori
    Yukiya Narita
    Hiroya Taniguchi
    Takashi Ura
    Masashi Ando
    Kei Muro
    Gastric Cancer, 2018, 21 : 1050 - 1057
  • [17] Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan
    Kondoh, Chihiro
    Kadowaki, Shigenori
    Komori, Azusa
    Narita, Yukiya
    Taniguchi, Hiroya
    Ura, Takashi
    Ando, Masashi
    Muro, Kei
    GASTRIC CANCER, 2018, 21 (06) : 1050 - 1057
  • [18] Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients
    Romain Coriat
    Olivier Mir
    Anatole Cessot
    Catherine Brezault
    Stanislas Ropert
    Jean-Philippe Durand
    Wulfran Cacheux
    Stanislas Chaussade
    François Goldwasser
    Investigational New Drugs, 2012, 30 : 376 - 381
  • [19] Modified FOLFOX-4 as First-line and Salvage Treatment in Advanced Gastric Cancer
    Baek, Yang Hyun
    Choi, Seok Reyol
    Jang, Jin Seok
    Roh, Myung Hwan
    Lee, Jong Hun
    Won, Jong Jin
    Lee, Chang Min
    HEPATO-GASTROENTEROLOGY, 2011, 58 (105) : 251 - 256
  • [20] Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients
    Coriat, Romain
    Mir, Olivier
    Cessot, Anatole
    Brezault, Catherine
    Ropert, Stanislas
    Durand, Jean-Philippe
    Cacheux, Wulfran
    Chaussade, Stanislas
    Goldwasser, Francois
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 376 - 381
12345